Many genetic and epigenetic alterations of proliferative signaling pathways and tumor suppressors are also characterized in the pathogenesis of CRC, such as the Wnt pathway, the TGF-β pathway, the (PI3K)-AKT pathway, the MAPK pathway, and the tumor protein p53 (TP53)2. This evidence concerns the gene TGFB1 and neoplasm.